76 related articles for article (PubMed ID: 30083824)
1. Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
König L; Dreyling M; Dürig J; Engelhard M; Hohloch K; Viardot A; Witzens-Harig M; Kieser M; Klapper W; Pott C; Herfarth K
Trials; 2019 Aug; 20(1):544. PubMed ID: 31470902
[TBL] [Abstract][Full Text] [Related]
2. Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.
Rai A; Nastoupil LJ; Williams JN; Lipscomb J; Ward KC; Howard DH; Lee D; Flowers CR
Leuk Lymphoma; 2017 Jul; 58(7):1570-1580. PubMed ID: 27830968
[TBL] [Abstract][Full Text] [Related]
3.
Dang YZ; Li X; Ma YX; Li XL; Yang T; Lu WL; Huang SG
Oncol Lett; 2019 Jan; 17(1):149-158. PubMed ID: 30655750
[TBL] [Abstract][Full Text] [Related]
4. End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
Kato K; Izutsu K; Nishikori M; Shibayama H; Maeda Y; Yoshimura K; Tateishi U; Miyamoto T; Matsuda Y; Ishikawa J; Rai S; Takahashi T; Yamauchi T; Matsumura I; Akashi K; Kanakura Y; Suzumiya J
Int J Hematol; 2024 Mar; ():. PubMed ID: 38519820
[TBL] [Abstract][Full Text] [Related]
5. Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma.
Figura N; Flampouri S; Mendenhall NP; Morris CG; McCook B; Ozdemir S; Slayton W; Sandler E; Hoppe BS
Adv Radiat Oncol; 2017; 2(2):197-203. PubMed ID: 28740932
[TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic.
Kohan A; Menon S; Murad V; Mirshahvalad SA; Kulanthaivelu R; Farag A; Ortega C; Metser U; Veit-Haibach P
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001619
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
Tilly H; Morschhauser F; Casasnovas O; Molina TJ; Feugier P; Gouill SL; Haioun C; Tournilhac O; Bouabdallah R; Gabarre J; Lamy T; Cabeçadas J; Becker S; Jardin F; Mounier N; Salles G;
Lancet Haematol; 2018 Sep; 5(9):e403-e410. PubMed ID: 30172345
[TBL] [Abstract][Full Text] [Related]
8. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
Gordon LI
Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
[No Abstract] [Full Text] [Related]
9. Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).
Ustun C; Morgan E; Moodie EEM; Pullarkat S; Yeung C; Broesby-Olsen S; Ohgami R; Kim Y; Sperr W; Vestergaard H; Chen D; Kluin PM; Dolan M; Mrózek K; Czuchlewski D; Horny HP; George TI; Kristensen TK; Ku NK; Yi CA; Møller MB; Marcucci G; Baughn L; Schiefer AI; Hilberink JR; Pullarkat V; Shanley R; Kohlschmidt J; Coulombe J; Salhotra A; Soma L; Cho C; Linden MA; Akin C; Gotlib J; Hoermann G; Hornick J; Nakamura R; Deeg J; Bloomfield CD; Weisdorf D; Litzow MR; Valent P; Huls G; Perales MA; Borthakur G
Cancer Med; 2018 Sep; 7(9):4447-4455. PubMed ID: 30117318
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A; Jacobsen E
Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
[TBL] [Abstract][Full Text] [Related]
11. The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma.
Barrington SF; Trotman J
Lancet Haematol; 2021 Jan; 8(1):e80-e93. PubMed ID: 33357487
[TBL] [Abstract][Full Text] [Related]
12. PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma.
Lo AC; James LP; Prica A; Raymakers A; Peacock S; Qu M; Louie AV; Savage KJ; Sehn LH; Hodgson D; Yang JC; Eich HTT; Wirth A; Hunink MGM
J Nucl Med; 2022 Apr; 63(4):543-548. PubMed ID: 34413148
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy in Follicular Lymphoma Staged by
Karsten IE; Reinartz G; Pixberg M; Kröger K; Oertel M; Friedrichs B; Lenz G; Eich HT
Biomedicines; 2021 May; 9(5):. PubMed ID: 34067779
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.
Tobin JWD; Rule G; Colvin K; Calvente L; Hodgson D; Bell S; Dunduru C; Gallo J; Tsang ES; Tan X; Wong J; Pearce J; Campbell R; Tneh S; Shorten S; Ng M; Cochrane T; Tam CS; Abro E; Hawkes E; Hodges G; Kansara R; Talaulikar D; Gilbertson M; Johnston AM; Savage KJ; Villa D; Morris K; Ratnasingam S; Janowski W; Kridel R; Cheah CY; MacManus M; Matigian N; Mollee P; Gandhi MK; Hapgood G
Blood Adv; 2019 Oct; 3(19):2804-2811. PubMed ID: 31570492
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with early-stage follicular lymphoma staged with
Ng SP; Khor R; Bressel M; MacManus M; Seymour JF; Hicks RJ; Wirth A
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):80-86. PubMed ID: 30083824
[TBL] [Abstract][Full Text] [Related]
16. Definitive radiotherapy for localized follicular lymphoma staged by
Brady JL; Binkley MS; Hajj C; Chelius M; Chau K; Balogh A; Levis M; Filippi AR; Jones M; Mac Manus M; Wirth A; Oguchi M; Vistisen AK; Andraos TY; Ng AK; Aleman BMP; Choi SH; Kirova Y; Hardy S; Reinartz G; Eich HT; Bratman SV; Constine LS; Suh CO; Dabaja B; El-Galaly TC; Hodgson DC; Ricardi U; Yahalom J; Hoppe RT; Mikhaeel NG
Blood; 2019 Jan; 133(3):237-245. PubMed ID: 30446493
[TBL] [Abstract][Full Text] [Related]
17. Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma.
Wirth A; Foo M; Seymour JF; Macmanus MP; Hicks RJ
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):213-9. PubMed ID: 18295982
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
